News & Comment

Filter By:

  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved, and where it is heading. This month, we are talking to Igor Adameyko (Department Chair at the Center for Brain Research of the Medical University of Vienna, Austria, and a group leader at the Karolinska Institutet, Sweden), a developmental biologist by training with research interests ranging from neural crest cell fate to aquatic life and a champion of a positive research culture.

    • Elisa Floriddia
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Nancy Ip, Morningside Professor of Life Science and president of the Hong Kong University of Science and Technology. We discussed her path from academia to industry and back, her experiences as a working mother and how she has helped scientific research in Hong Kong to flourish.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Bill Martin, Global Therapeutic Area Head, Neuroscience at Johnson & Johnson Innovative Medicine. We discussed the challenges and opportunities ahead for the development of treatments for psychiatric disease.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved, and where it is heading. This month, we are talking to Ukpong Eyo (Associate Professor of Neuroscience at the University of Virginia, USA), a glial biologist interested in the role of microglia in neurodevelopment, health and disease, about science, family, and the benefits of finding your balance.

    • Elisa Floriddia
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Kelsey Martin, Executive Vice President of Autism and Neuroscience at the Simons Foundation and Professor in the Department of Biological Chemistry at the University of California, Los Angeles (UCLA), where she previously served as the Dean of the David Geffen School of Medicine. We discussed the pleasures of studying neuronal cell biology and her leadership roles.

    • Shari Wiseman
    Q&A
  • In 2022, we began a pilot to facilitate data sharing for manuscripts submitted to Nature Neuroscience. Here, we analyze its effects on research data availability and reflect on the importance of facilitating open science.

    Editorial